Lv31
386 积分 2024-12-04 加入
Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial
3小时前
待确认
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
17天前
已完结
Toripalimab (anti-PD-1) versus High-Dose Interferon-α2b as Adjuvant Therapy in Resected Mucosal Melanoma: A Phase II Randomized Trial
20天前
已完结
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial
25天前
已完结
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
1个月前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
1个月前
已完结
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT Trial embedded phase II population
5个月前
已完结
Targeting the EGFR signalling pathway in metastatic colorectal cancer
5个月前
已完结
Stereoselective Synthesis of trans-3-Amino-2,2,4,4-tetramethylcyclobutanol
11个月前
已完结
皖公网安备34019202002308
